Eurointervention

Article	Citations
Transcatheter treatment for tricuspid valve disease	134
Percutaneous coronary intervention for bifurcation coronary lesions: the 15<sup>th</sup> consensus document from the European Bifurcation Club	130
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores	125
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcircula	81
Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study	72
Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI – design and rationale of ILUMIEN IV: OPTIMAL PCI	69
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation	59
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients	55
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial	55
Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques	52
Diagnostic performance of intracoronary optical coherence tomography-based versus angiography-based fractional flow reserve for the evaluation of coronary lesions	48
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy	46
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry	43
First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study	42
Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial	41
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry	40
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation	39
Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial	38
Ultrasound-guided access to the distal radial artery at the anatomical snuffbox for catheter-based vascular interventions: a technical guide	38
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	37
Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism&nbsp;	36
Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey	33
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	33
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study	33
Incidence of “shocktopics” and asynchronous cardiac pacing in patients undergoing coronary intravascular lithotripsy	32

Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair	31
Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting	30
Management of cardiogenic shock	30
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study	29
A deep learning algorithm for detecting acute myocardial infarction	28
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis	28
Training and validation of a deep learning architecture for the automatic analysis of coronary angiography	28
National French registry of spontaneous coronary artery dissections: prevalence of fibromuscular dysplasia and genetic analyses	28
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial	27
Transcatheter aortic valve implantation in degenerated surgical aortic valves	26
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	25
Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease	25
Recanalisation of coronary chronic total occlusions	24
Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study	23
Association of coronary microvascular endothelial dysfunction with vulnerable plaque characteristics in early coronary atherosclerosis	23
Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial	23
Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk	23
Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study	23
Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure	22
A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention	22
Screening for transcatheter mitral valve replacement: a decision tree algorithm	22
Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study	22
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification	21
The SYNTAX score on its way out or … towards artificial intelligence: part I	20
Principles and pitfalls in coronary vasomotor function testing	20
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair	20
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry	19
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	19
Clinical outcomes by angiographic type of spontaneous coronary artery dissection	19
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic	18
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	18
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2	18
Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry	18
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions	18
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis	18
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing	18
Intravascular lithotripsy for lesion preparation in patients with calcific distal left main disease	18
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	18
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation	17
Mitral valve transcatheter edge-to-edge repair	17
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis	17
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial	17
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial	17
A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous	16
Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospe	16
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc	16
Heterogeneity of debris captured by cerebral embolic protection filters during TAVI	16
Reproducibility of quantitative flow ratio: the QREP study	16
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial	16
Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study	15

Detection of cholesterol crystals by optical coherence tomography	15
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	15
A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation	15
The SYNTAX score on its way out or … towards artificial intelligence: part II	15
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	15
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes	15
Detection of optical coherence tomography-defined thin-cap fibroatheroma in the coronary artery using deep learning	15
Transseptal puncture: procedural guidance, challenging situations and management of complications	15
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture	15
Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)	14
Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry	14
Echocardiographic guidance in transcatheter structural cardiac interventions	14
Device entrapment during percutaneous coronary intervention of chronic total occlusions: incidence and management strategies	14
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial	14
Device-related thrombus following left atrial appendage occlusion	14
Systematic review and meta-analysis of valve-in-valve transcatheter aortic valve replacement in patients with failed bioprosthetic aortic valves	14
Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial	13
A novel supra-annular plane to predict TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane	13
Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series	13
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions	13
Safety of absolute coronary flow and microvascular resistance measurements by thermodilution	13
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification	13
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial	12
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	12
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study	12
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	12
Coronary artery cannulation after transcatheter aortic valve implantation	12
Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis	12
Robotics, imaging, and artificial intelligence in the catheterisation laboratory	11
Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique	11
Lipid-lowering therapy and percutaneous coronary interventions	11
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study	11
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance	11
Near-infrared spectroscopy carotid plaque characteristics and cerebral embolism in carotid artery stenting	10
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak	10
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data	10
Outcomes in nonagenarians undergoing transcatheter aortic valve implantation: a nationwide analysis	10
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study	10
Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials	10
Outcomes of directional atherectomy for common femoral artery disease	10
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial	10
Transient acute right coronary artery deformation during transcatheter interventional tricuspid repair with the Cardioband tricuspid system	10
Stroke after transcatheter edge-to-edge mitral valve repair: a systematic review and meta-analysis	10
Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial	10
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	9
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation	9
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial	9
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials	9
Comparison of fractional flow reserve, instantaneous wave-free ratio and a novel technique for assessing coronary arteries with serial lesions	9
Impact of chronic total coronary occlusion revascularisation on infarct-related myocardial scars responsible for recurrent ventricular tachycardia	9
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial	9
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	9
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)	9
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial	9
Radial artery dilatation to improve access and lower complications during coronary angiography: the RADIAL trial	8
Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study	8
Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease	8
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation	8
Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices	8
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial	8
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention	8
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease	8
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	8
Long-term changes in coronary physiology after aortic valve replacement	8
Management of patients with mitral regurgitation ineligible for standard therapy undergoing TMVI screening	7
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules	7
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up	7
Complementary roles of intracardiac and transoesophageal echocardiography in transcatheter tricuspid interventions	7
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	7
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial	7
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	7
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience	7
Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system	7
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow	7
Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation	7
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)	7
Predictors and clinical impact of thrombosis after transcatheter mitral valve implantation using balloon-expandable bioprostheses	7
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary	7
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial	7
Long-term safety of drug-coated devices for peripheral revascularisation	7

An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation	6
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry	6
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	6
Transoesophageal echocardiography guidance with paediatric probes in adults undergoing left atrial appendage occlusion	6
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	6
Anticipating coronary obstruction with three-dimensional printing in transcatheter aortic valve implantation	6
Consolidating the value of the standardised ARC-HBR definition	6
Transcatheter valve-in-valve implantation versus redo surgical mitral valve replacement in patients with failed mitral bioprostheses	6
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	6
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial	6
Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review	6
Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery diseas	6
Complex PCI: time for a universal definition	6
Deep sedation versus general anaesthesia for transcatheter mitral valve repair: an individual patient data meta-analysis of observational studies	6
Percutaneous reintervention on aortic coarctation stenting	6
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	6
Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial	6
Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents	6
Spontaneous echo contrast, left atrial appendage thrombus and stroke in patients undergoing transcatheter aortic valve implantation	6
Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial	6
Radiation protection measures and sex distribution in European interventional catheterisation laboratories	6
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	5
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study	5
Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement	5
Transseptal puncture in patients with septal occluder devices during catheter ablation of atrial fibrillation	5
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report	5
Outcomes of myocardial fibrosis in patients undergoing transcatheter aortic valve replacement	5
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial	5
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure	5
Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation	5
Percutaneous access and closure using the MANTA vascular closure device in transaxillary transcatheter aortic valve implantation	5
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	5
Transcatheter valve repair in congenitally corrected transposition of the great arteries	5
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation	5
Clinical impact of intervention strategies after failed transcatheter mitral valve repair	5
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	5
Outcomes of non-ischaemic coronary lesions with high-risk plaque characteristics on coronary CT angiography	5
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	5
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	5
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry	5
Pulmonary haemodynamic effects of interatrial shunt in heart failure with preserved ejection fraction: a preclinical study	5
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study	5
A randomised comparison of monoplane versus biplane fluoroscopy in patients undergoing percutaneous coronary intervention: the RAMBO trial	5
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	5
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation	4
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion	4
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	4
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction	4
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial	4
Direct visualisation of the BASILICA technique post TAVR to enhance coronary flow	4
Cusp overlap technique during valve-in-valve TAVI using the novel Navitor transcatheter heart valve	4
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials	4
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	4
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination	4
Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One	4
A novel implantable left atrial sensor for pressure monitoring in heart failure	4
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2	4
Procedural and short-term outcomes of occluding large left atrial appendages with the LAmbre device	4
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	4
Fatal acute mesenteric ischaemia following transcatheter aortic valve replacement	4
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	4
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications	4
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	4
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial	4
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score	4
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of	4
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	4
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?	3
Percutaneous mitral valve leaflet repair: ongoing directions and future perspectives	3
Continuous intracoronary versus standard intravenous infusion of adenosine for fractional flow reserve assessment: the HYPEREMIC trial	3
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	3
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation	3
Fractional flow reserve-guided PCI in patients with and without left ventricular hypertrophy: a DANAMI-3-PRIMULTI substudy	3
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)	3
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction	3
Long-term follow-up of patients with contained annulus ruptures after TAVI: the EuropeaN COntained RupturE (ENCORE) registry	3
Pumping up best practices in radial artery access: prolonged occlusion flow-mediated dilation improves radial artery access success	3
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system	3
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial	3
Transcatheter interventions for heart failure	3
One-month DAPT after acute coronary syndrome: too short or not too short?	3
Outcomes of excimer laser-contrast angioplasty for stent underexpansion	3
A direct wire pacing device for transcatheter heart valve and coronary interventions: a first-in-human, multicentre study of the Electroducer Sleeve	3
Thrombolysis in ST-elevation myocardial infarction is not dead	3
Angiographic predictors of unplanned rotational atherectomy in complex calcified coronary artery disease: a pooled analysis from the randomised ROTAXUS and PREPARE-CALC trials	3
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial	3
Non-implant valve repair for calcific aortic stenosis: the Leaflex study	3
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra	3
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial	3
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	3
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	2
Reply: Composite endpoints in clinical trials - simplicity or perfection?	2
A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair	2
Late structural discontinuity after bioresorbable vascular scaffold implantation in patients with in-stent restenosis	2
Technical considerations for repeat transcatheter aortic valve implantation in a failing Direct Flow Medical transcatheter heart valve	2